Co-Founder · CEO & Chief Scientist
CEO & Chief Scientist, AMA Regenerative Medicine & Skincare
The principal scientist behind AMA’s IRM Medicine protocols — and a medical entrepreneur, inventor and FLCCC-featured speaker on regenerative approaches to chronic illness.
Asher Milgrom — the youngest of four siblings — was born in Virginia to Josephine, a professor of the theology of art, and Jacob, a rabbi and world-renowned Bible scholar. His childhood home was a crossroads for some of the great scholars and thinkers of the 20th century, from clergy to existential philosophers to particle physicists. Basking in that celebration of the mind, he learned early that thought was the antidote to boredom, and curiosity the seed of knowledge.
His college years were an assemblage of explorations — from automotive mechanics to pioneering in-situ marine-biology research as a staff research associate at the Scripps Institution of Oceanography. He supported himself working as a cantor and teaching adult courses in Judaic philosophy and mysticism, before venturing into medicine.
Asher received a full scholarship to an M.D./Ph.D. program at the University of Health Sciences and the University of Chicago’s Pritzker School of Medicine, studying neuro-biochemistry. At the very end of his training, a rare brain infection put him in a coma. He survived completely intact, and — having “touched the face of God and lived” — emerged with a transformed perspective. Shortly after, he chose to leave the practice of medicine to develop its science.
In 1999 Asher founded and funded American Medical Aesthetics & Wellness (AMA Regenerative Medicine & Skincare). He is the principal architect of its business strategy and the principal scientist behind its medical protocols. With Dr. Pien, he developed holistic “multiple-modality” protocols that produce extraordinary clinical results with minimal downtime, and pioneered the integration of Physiological Regulating Medicine into proprietary laser protocols. He is the inventor of the Hemodynamic Swirling Apparatus (HSA-2000), patent pending, for use with hyperbaric ozone therapy.
Selected media & speaking
"Featured speaker on the role of EBOO/F apheresis, high-dose ozone therapy, and IV therapies including Methylene Blue and NAD in the treatment of Long COVID."
FLCCC Educational Conference
"Cited offering ozone therapy options to improve mitochondrial dysfunction — a common driver of post-viral fatigue."
The Epoch Times — Epoch Health
"Presented a novel method of performing Ozone Major Autohemotherapy (MAH) without anticoagulants."
American Academy of Ozonotherapy
Featured in & affiliated with





Science-based healing
Every protocol at AMA traces back to the IRM framework Dr. Milgrom built. Start with a 60-minute consultation with our physician team.